| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.00B | — |
| R&D Expense | $68.0M | +5.4% |
| SG&A Expense | $25.1M | +9.0% |
| Operating Income | -$93.1M | -6.3% |
| Interest Expense | $14.9M | +477.1% |
| Income Tax | $0 | — |
| Net Income | -$106.0M | -17.8% |
| EPS (Basic) | -$1.21 | +4.7% |
| EPS (Diluted) | -$1.21 | +4.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.3M | -83.9% |
| Current Assets | $138.1M | -27.7% |
| Total Assets | $141.9M | -29.9% |
| Current Liabilities | $15.4M | -15.9% |
| Total Liabilities | $105.7M | +52.3% |
| Stockholders' Equity | $36.2M | -72.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$84.1M | -21.1% |
| Capital Expenditures | $148K | +70.1% |
| Investing Cash Flow | -$46.0M | -194.6% |
| Financing Cash Flow | $24.6M | -79.3% |
| Free Cash Flow | -$84.2M | -21.2% |